Abstract |
Protein tyrosine phosphatase 1B (PTP1B) has been implicated as one of the key negative regulators of insulin and leptin signal transduction pathways. PTP1B deficient mice are more sensitive to insulin, and have improved glycemic control and resistance to diet-induced obesity than the wild-type control mice. Inhibiting PTP1B action using antisense oligonucleotides and small molecule inhibitors represents novel therapeutic approach for the treatment of insulin resistance, type II diabetes, and obesity. The rapid development of this field is evidenced by the increasing number of patents and publications in recent years. This review will highlight the recent advances in various approaches for attenuating PTP1B action, particularly small molecule PTP1B inhibitors, and the challenges associated with developing PTP1B inhibitors with drug like properties.
|
Authors | Gang Liu |
Journal | Current medicinal chemistry
(Curr Med Chem)
Vol. 10
Issue 15
Pg. 1407-21
(Aug 2003)
ISSN: 0929-8673 [Print] United Arab Emirates |
PMID | 12871138
(Publication Type: Journal Article, Review)
|
Chemical References |
- Acetates
- Benzoates
- Enzyme Inhibitors
- Hydroquinones
- Oligonucleotides, Antisense
- Organophosphonates
- Salicylates
- dephostatin
- Phosphotyrosine
- PTPN1 protein, human
- Protein Tyrosine Phosphatase, Non-Receptor Type 1
- Protein Tyrosine Phosphatases
- phenoxyacetic acid
|
Topics |
- Acetates
(chemistry, pharmacology)
- Animals
- Benzoates
(chemistry, pharmacology)
- Enzyme Inhibitors
(chemistry, pharmacology, therapeutic use)
- Humans
- Hydroquinones
(chemistry, pharmacology)
- Insulin Resistance
(physiology)
- Molecular Mimicry
- Oligonucleotides, Antisense
(therapeutic use)
- Organophosphonates
(chemistry, pharmacology)
- Phosphotyrosine
(chemistry, metabolism)
- Protein Tyrosine Phosphatase, Non-Receptor Type 1
- Protein Tyrosine Phosphatases
(antagonists & inhibitors, chemistry, metabolism)
- Salicylates
(chemistry, pharmacology)
- Structure-Activity Relationship
|